NYSE: HCA · Industrial Applications and Services · 7 alerts · CIK 860730
Share price
$511.78Close, Nov 16
Market cap
$107B
Shares outstanding
208.89MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-General Medical & Surgical Hospitals, NECSIC 8062
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All HCA Healthcare, Inc. filings on SEC EDGAR ↗
Erica Rossitto, SVP & Chief Nurse Executive, sold 3,500 shares of HCA Healthcare, Inc. at $505.81 a share, worth $1.77M in total on Nov 10, 2026. Shares held after the trade: 13,426 (-20.7%).
HCA Healthcare EVP and Chief Clinical Officer Michael J. Schlosser Sells $594K of Stock
Michael J. Schlosser, EVP and Chief Clinical Officer, sold 1,200 shares of HCA Healthcare, Inc. at $494.65 a share, worth $594K in total on Nov 4, 2026. Shares held after the trade: 1,443 (-45.4%).
HCA Healthcare EVP and COO Jon M. Foster Sells $15.9M of Stock
Jon M. Foster, EVP and COO, sold 31,713 shares of HCA Healthcare, Inc. at $491.98 to $514.07 a share (average $500.98) in 8 transactions, worth $15.9M in total between Nov 4, 2026 and Nov 6, 2026. Shares held after the trade: 10,000 (-12.9%).
HCA Healthcare $6.5B Debt Financing with CSC Delaware Trust Company
HCA Healthcare's subsidiary, HCA Inc., completed a massive $6.5 billion public offering of senior notes across seven different tranches with maturities ranging from 2028 to 2056. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, Inc. and were issued under a shelf registration statement to manage the company's long-term capital structure.
HCA Healthcare $1.2B Debt Financing with Mizuho Securities USA LLC
HCA Healthcare's subsidiary, HCA Inc., has commenced a public offering of senior unsecured notes to fund general corporate purposes. The company intends to use the proceeds to redeem $1.200 billion of its 4.500% senior notes due February 2027 and repay borrowings under its commercial paper program and credit facility.
HCA Healthcare reported revenues of $19.849 billion for the third quarter of 2026, a 3.6% increase over the prior year, while net income attributable to the company slightly decreased to $1.579 billion. Despite the slight dip in net income, diluted earnings per share rose to $7.27 from $6.96, driven by significant share repurchases totaling $6.605 billion during the first nine months of the year.
HCA Healthcare reported third quarter 2026 revenues of $19.85 billion, a 3.6% increase year-over-year, despite an estimated $400 million headwind from an unfavorable payer mix shift. The company also declared a quarterly cash dividend of $0.78 per share and indicated that full-year results are expected to be in the upper half of its previously issued guidance range.
Term
Q3 2026
“I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities, and our disciplined culture. Despite the challenges brought about by federal policy changes this year, our colleagues have continued to provide high-quality care to patients, and we believe HCA Healthcare is positioned to end the year positively.”
Sam Hazen, Chief Executive Officer of HCA Healthcare